H2NVAC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H2NVAC, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ [Phase 1]